132P Neoadjuvant zanidatamab for stage I node-negative HER2- positive breast cancer (BC)
| Autor: | Valero, V., Mouabbi, J., Alonzo, H., Ilheme, A. Nwosu, Murthy, R., Huang, X., Qiao, W., Patel, M., Pohlmann, P.R., Rauch, G., Checka, C., Hunt, K., Tripathy, D., Meric-Bernstam, F., Symmans, F. |
|---|---|
| Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|